View Entire Collection
By Clinical Topic
Diabetes – Summer 2012
Future of Nursing Initiative
Heart Failure - Fall 2011
Influenza - Winter 2011
Nursing Ethics - Fall 2011
Trauma - Fall 2010
Traumatic Brain Injury - Fall 2010
Fluids & Electrolytes
TUESDAY, Oct. 11 (HealthDay News) -- Placental protein 13 (PP13 or galectin 13) forms perivenous aggregates that attract and activate maternal immune cells to create decidual zones of necrosis (ZONEs), which facilitate trophoblast invasion and conversion of the maternal spiral arterioles in preeclampsia, according to a study published online Oct. 11 in Reproductive Sciences.
Harvey J. Kliman, M.D., Ph.D., from Yale University in New Haven, Conn., and colleagues assessed the role of PP13 in trophoblast invasion and decidual necrosis in early preeclampsia. Immunohistochemical analysis was carried out on 20 elective pregnancy termination specimens between 6 and 15 weeks of gestation to assess PP13, immune cells, human placental lactogen, cytokeratin, and markers of apoptosis.
The investigators found that PP13 was localized to the occasional multinucleated luminal trophoblasts within converted decidual spiral arterioles, and to syncytiotrophoblasts in the chorionic villi. PP13 staining was not seen in cytotrophoblasts, anchoring trophoblasts, or invasive trophoblasts. Extracellular PP13 aggregates were localized around ZONEs which comprised decidual veins associated with T-cells, neutrophils, and macrophages.
"Our studies suggest that PP13-mediated ZONEs within normal human gestational decidua may be a novel mechanism to divert maternal immune surveillance away from the spiral arterioles," the authors write.
Several of the study authors disclosed financial ties with Diagnostic Technologies Ltd.
Full Text (subscription or payment may be required)
Sign up for our free enewsletters to stay up-to-date in your area of practice - or take a look at an archive of prior issues
Join our CESaver program to earn up to 100 contact hours for only $34.95
Explore a world of online resources
Back to Top